Ian Krietzberg

One week after Trump dragged Silicon Valley’s top C.E.O.s halfway across the world to extract various business deals with Xi Jinping, the crew returned to Washington with more questions than answers. Among them: Does the White House have a unified policy on A.I.? And is China a competitor, or a customer?

With stratospheric funding and a slew of founding talent from OpenAI, Mira Murati’s Thinking Machines Lab seemingly had everything an A.I. startup needed for escape velocity. But as it approaches its 15-month mark, the company has little to show for all that promise and capital.

The full-scale rollout of Google’s newish A.I.-assisted search feature raises more questions than answers—but it also underscores the tech giant’s extraordinary advantages at a time when other hyperscalers haven’t addressed consumer skepticism about chatbots.

Michigan Senate candidate Mallory McMorrow is jumping in front of the unstoppable A.I. freight train, betting that anxious voters are hungry for a pragmatic, informed approach that finds a reasonable sweet spot between Bernie Sanders and David Sacks. Herewith, the details of her plan.

An incisive conversion with Marc Zao-Sanders, author of the Harvard Business Review’s latest report on how consumers are actually using A.I.

With public opinion—and a slew of presidential hopefuls—beating back A.I.’s “no rules” agenda, the lobbyist armies of Andreessen Horowitz and OpenAI are suddenly supporting safeguards they rejected just a year ago.

Of all the altruistic promises of A.I., none has been as tantalizing to frontier labs as curing disease. The Allen Institute has now launched an ambitious tech-fueled initiative, with $400 million and dozens of high-powered partnerships, to attack the most tantalizing target of all: brain disease.

Sanders wants 50% of A.I. companies. Trump wants 'pieces.' OpenAI wants a dividend fund. A surprising political consensus is taking shape.

A captivating conversation with Márcia Mayer, a former Pixar producer who now works at Google DeepMind, about the lab’s new A.I.-assisted short film that’s become the talk of Tribeca.

Whatever happens on primary night, the A.I. dark money battle over Alex Bores is merely the opening of a broader industry proxy war—with hundreds of millions of dollars ready to deploy into 2028.